What is the ELOVL2 gene?
Very-long-chain fatty-acid elongase involved in EPA, DPA, DHA, and long-chain PUFA handling.
How ELOVL2 affects metabolism
When ELOVL2-related function is shifted, the practical effect is interpreted through lipoprotein transport, triglyceride-rich particles, LDL clearance, or liver lipid handling. This does not mean the pathway is active or impaired right now; it means the gene can help prioritize what to check next.
What happens when ELOVL2 is altered
Altered ELOVL2 signal should be treated as a DNA-based tendency, not a diagnosis. 1 claim currently passes the report-use gate. The useful question is whether symptoms, labs, and lifestyle context line up with the pathway signal.
Curated SNP evidence for ELOVL2
These SNPs come from the approved study-level evidence model. Each claim is scored from curated study rows, then gated before it can influence pathway scoring.
Evidence-backed report connection
ELOVL2 currently has 1 curated SNPs, 1 claim-level scores, and 1 claims eligible for pathway scoring.
Open the sample reportrs953413ELOVL2 rs9534131 claims · 2 study rows
biomarker tendency · A
omega-3 long-chain PUFA response tendency
rs953413 A in ELOVL2 is associated with altered EPA/DHA proportions and a stronger EPA or omega-3 index increase after fish-oil supplementation.
ELOVL2 rs953413 A is staged as a fish-oil response and long-chain omega-3 PUFA biomarker allele.
Show study evidence
Common symptoms people report
- unexpected cholesterol or triglyceride results
- family context around lipid markers
- unclear ApoB, LDL-C, HDL-C, or triglyceride patterns
Biomarkers to validate
ApoB
Shows the number of atherogenic particles more directly than total cholesterol.
LDL-C, HDL-C, and triglycerides
Gives the basic lipid pattern that DNA can help contextualize.
Lp(a) or liver enzymes when relevant
Adds context for inherited lipid risk or liver lipid handling.
Where DNA analysis helps
DNA helps decide whether ELOVL2 deserves attention inside the broader Lipids pathway. It is most useful when combined with biomarkers instead of used as a standalone answer.
Example interpretation
ELOVL2 may add context to lipoprotein transport, triglyceride-rich particles, LDL clearance, or liver lipid handling, especially when its SNP evidence lines up with other genes in the same pathway.
Suggested validation: ApoB.
What to do next
- Review the Lipids pathway result before interpreting ELOVL2 on its own.
- Use relevant biomarkers to confirm whether this DNA tendency is visible in current biology.
- Treat supplement or nutrition decisions as follow-up steps only after the pattern fits symptoms or labs.
Upload your DNA file and receive a structured metabolic pathway analysis with prioritized insights and suggested validation markers.
Get My DNA Report